Valerie Bekker

Johannesburg, GT, South Africa

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

Journal: PLOS global public health
Published: May 10, 2024

Identification of RTS,S/AS01 vaccine-induced humoral biomarkers predictive of protection against controlled human malaria infection.

Identification of RTS,S/AS01 vaccine-induced humoral biomarkers predictive of protection against controlled human malaria infection.

Journal: JCI insight
Published: January 21, 2024

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.

Journal: PLoS pathogens
Published: January 27, 2023

Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans.

Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans.

Journal: NPJ vaccines
Published: March 25, 2022

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.

Journal: Nature medicine
Published: November 16, 2021

Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s.

Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s.

Journal: Frontiers in immunology
Published: October 01, 2021

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.

Journal: PLoS pathogens
Published: August 10, 2021

Infection of Chinese Rhesus Monkeys with a Subtype C SHIV Resulted in Attenuated In Vivo Viral Replication Despite Successful Animal-to-Animal Serial Passages.

Infection of Chinese Rhesus Monkeys with a Subtype C SHIV Resulted in Attenuated In Vivo Viral Replication Despite Successful Animal-to-Animal Serial Passages.

Journal: Viruses
Published: January 19, 2021

Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape.

Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape.

Journal: Cell reports
Published: June 15, 2020

HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth.

HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth.

Journal: Cell host & microbe
Published: May 07, 2018

Correction for Anthony et al., "Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope".

Correction for Anthony et al., "Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope".

Journal: Journal of virology
Published: April 15, 2018

Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation.

Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation.

Journal: Nature communications
Published: March 06, 2018
Showing 1-12 of 14

Last Updated: 09/26/2026